Connect with us
All listed pharmaceutical companies have advanced on the stock market, but Grifols, whose shares have fallen by more than 12%, has weighed down the sector. The...
Germany is not yet particularly well positioned in research and development of novel gene and cell therapies. Most studies are carried out in the USA (48%)...
Foren Method, a Madrid-based startup, is looking for $2.25 million (€2 million) to carry out its clinical trial, for the new therapeutic tool the company developed....
Biotechnology companies have many growth levers and are to be favored for their defensive qualities, in the context of the current health and economic crisis. The...
The Gosselies Biopark company has filed an IPO application with the SEC, the U.S. regulator, has announced the Wall Street Stock Exchange with a strong technology...
The Basque Country-based startup gets funding from the Botín Foundation, Seed Capital Bizkaia and Wa4steam to improve Fine Birth, a device to detect false signs of...
In the race for a reliable vaccine against the new coronavirus, five companies from the international biotech sector have become the focus of investors in recent...
The company Uriach hopes to maintain "stability" in investments for the rest of the year and to boost its line of cannabis products. The B2B business...
The Burgundian biotech company announced on Monday, June 15th, the success on different efficacy criteria of its lanifibranor molecule to treat patients suffering from Non-Alcoholic Steatohepatitis,...
All the listed pharmaceutical companies have taken a step back on the stock exchange, with the exception of Pharma Mar and Reig Jofre. Pharma Mar has...
 |
|
 |  |
 |
|